An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.
Source summary generated July 17, 2026; this date does not indicate completed review.
Quotes from three independent practitioners, with their sources. Research context only.
What it is and how it works
From the published literature on NAD+; the papers are listed at the end. Research summary, not a recommendation.
What it is
NAD+ (nicotinamide adenine dinucleotide) is a small coenzyme, not a peptide, found in every living cell. It was discovered in yeast in 1906 and is built from vitamin B3 (niacin and its relatives) and the amino acid tryptophan. Levels in many tissues decline with age in animals and in some human studies, which led to interest in raising it, either with oral precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) or with NAD+ itself given by infusion or injection. NAD+ is not an approved drug for any condition; most controlled human trials have tested the oral precursors rather than NAD+ itself.
How it works
NAD+ is an electron carrier: in the mitochondria it picks up electrons from broken-down food and delivers them to the chain that makes ATP, the cell's energy currency. It is also consumed as fuel by several families of enzymes: sirtuins (proteins that regulate gene activity and metabolism in response to energy status), PARPs (which repair damaged DNA) and CD38 (an immune-cell enzyme whose activity rises with age and inflammation). When these enzymes use up NAD+ faster than the body can rebuild it, levels fall, and animal studies linked restoring NAD+ to better mitochondrial function, metabolism and resistance to age-related decline. NAD+ itself does not enter cells easily; when infused into the blood it was rapidly broken down into smaller pieces, and the body rebuilds NAD+ inside cells from those pieces and from precursors.
What it has been studied for
Age-related decline in metabolism and mitochondrial function (reviews of animal and human studies)
Raising blood NAD+ levels and tolerability in middle-aged and older adults (randomized trials of oral precursors)
Muscle insulin sensitivity in prediabetic women (randomized trial of NMN)
Cognition in older adults with mild cognitive impairment (randomized trial of NR)
What happens to directly infused NAD+ in the body (small human pilot study)
Strength of the evidence
Early human studiesNAD+ given by infusion or injection has only small uncontrolled human data; randomized placebo-controlled trials exist for the oral precursors NR and NMN, which raised NAD+ levels with mixed results on health outcomes.
What the literature reports on safety
In randomized trials lasting weeks to months the oral precursors NR and NMN were generally well tolerated, and a 2026 systematic review concluded that clinical benefits for ageing and wellness remain inconclusive and that longer, larger trials are needed. Published safety data on direct NAD+ infusion or injection are limited to small studies. NAD+ is not an FDA-approved drug for any use; in the FDA's September 2023 compounding review it was placed in Category 1 (bulk substances under evaluation), not on the significant-safety-risk list.
Found that NAD+-boosting supplements reliably raised NAD+-related markers and were generally well tolerated, but clinical benefits in humans were inconclusive.
In a placebo-controlled crossover trial, oral NR raised NAD+ in blood cells, was well tolerated, and hinted at lower blood pressure and arterial stiffness that needed confirming.
Case series · Grant R, Berg J, et al. · Frontiers in Aging Neuroscience (2019) · PMID 31572171
In a small human pilot, infused NAD+ disappeared from the blood almost completely for the first two hours, consistent with rapid breakdown, before levels and breakdown products began to rise.
Sources checked: PubMed (E-utilities esummary and abstracts on every PMID), FDA 503A bulk drug substances category list (September 2023 update), written 2026-11-06.
Hunter Williams, in his own words
Figures quoted, not recommended. These are Hunter Williams' descriptions, not an agreed treatment protocol.
7 quotations from his library pages, each with its source. A quote marked with a product name is about a blend that includes NAD+.
What he says it is for
“By age 50, NAD+ levels have dropped about 50% in most people.”
8 earlier videos were removed from YouTube; titles kept for the record
NAD+ Is My New Favorite Compound - Unbreakable Podcast 298 (102×) · 2025-10-31read the hosted transcript
MOTS-C, NAD+ and SS-31 (solving mitochondrial damage) - Dr Trevor Bachmeyer (72×) · 2026-01-08read the hosted transcript
Does MOTS-C Make You Tired? Here's the solution - Dr Trevor Bachmeyer (150×) · 2026-03-18read the hosted transcript
Why Your Injuries Heal SO SLOW (It's Not Rest) - Dr Trevor Bachmeyer (150×) · 2026-04-18read the hosted transcript
Retatrutide and 5-Amino-1-MQ Combined - Dr Trevor Bachmeyer (93×) · 2026-02-27read the hosted transcript
The Longevity Stack (Fire Your Longevity Clinic) Unbreakable Podcast 198 (34×) · 2025-07-18read the hosted transcript
Is Long-Term Methylene Blue Use Safe? - Dr Trevor Bachmeyer (33×) · 2026-04-07read the hosted transcript
The Entire Routine And Supplement Stack - Unbreakable Podcast 232 (27×) · 2025-08-23read the hosted transcript
Ask the NAD+ Librarian
Answers are generated from captured sources and may omit context or contain errors. Check the supporting passages.
What have the teachers said about NAD+? Ask what it is, what they say it does, or where they discuss it. Questions about doses or personal use: ask your own clinician.
AI chat. To generate a reply, your question and recent chat history may be processed by Cloudflare Workers AI, Groq, Google Gemini or OpenRouter, depending on availability. Keep personal health details out of the chat and check the cited sources. Research use only; not medical advice.
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.